Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels
Authors:
Open Access
- 16 December 2019
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 19 (1) , 1-8
Abstract
Background: Accumulating evidence suggests that serum vascular endothelial growth factor (VEGF) in many neurobiological processes potentially contributes to the pathophysiology of psychiatric disorders, particularly cognitive decline. The purpose of this study was to explore the differences in neurocognition, social cognition and VEGF among remitted first-episode schizophrenic patients, non-remitters and normal control subjects. Moreover, we investigated the association between serum VEGF levels and cognitive functions.Method: 65 remission (RS) and 45 nonremission patients (NRS) after first-episode schizophrenia, as well as 58 healthy controls (HC) were enrolled in this study. Social cognition was assessed using the Chinese Facial Emotion Test (CFET); neurocognition was measured with a test battery consisting of Hopkins Verbal Learning Test-Revised, Verbal Fluency Test, Trail Making Tests, Digit Span Tests (DST) and Stroop Tests. Blood samples were collected for VEGF measurements. Data was analyzed with SPSS 22.0 (Chicago, IL, USA).Results: On nearly all neurocognitive tests (except for DST), RS performed significantly worse than HC but better than NRS (P < 0.05). NRS, but not RS, exhibited markedly poorer social cognition than HC (except for Happiness and Surprise subscales of the CFET) (P < 0.05). VEGF levels showed a gradient change among three groups (HC > RS > NRS).Conclusion: Compared to HC, RS demonstrated poorer neurocognitive but intact social cognition functioning. These results indicate that VEGF levels decreased gradually with the severity of cognitive impairment in schizophrenia. VEGF may be involved in the pathological mechanism of cognitive performance in RS.Keywords
Funding Information
- Scientific Research Foundation of Jiangsu Provincial 333 Project (BRA2015541, BRA2016555)
- Medical Scientific Research Project of Jiangsu Provincial Commission of Health and Family Planning (No. H2018041)
- Medical youth talent projects in Jiangsu Province (No. QNRC2016314)
- Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX18_1497)
This publication has 54 references indexed in Scilit:
- Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brainBMC Complementary and Alternative Medicine, 2012
- Deficits in Domains of Social Cognition in Schizophrenia: A Meta-Analysis of the Empirical EvidenceSchizophrenia Bulletin, 2012
- Reversible modulations of neuronal plasticity by VEGFProceedings of the National Academy of Sciences, 2011
- Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remissionSchizophrenia Research, 2009
- Social Cognition Deficits Among Individuals at Familial High Risk for SchizophreniaSchizophrenia Bulletin, 2009
- VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusionExperimental Neurology, 2008
- Influence of Vascular Endothelial Growth Factor Variation on Human Hippocampus MorphologyBiological Psychiatry, 2008
- VEGF Gene and Phenotype Relation with Alzheimer's Disease and Mild Cognitive ImpairmentRejuvenation Research, 2006
- Remission in Schizophrenia: Proposed Criteria and Rationale for ConsensusAmerican Journal of Psychiatry, 2005
- VEGF links hippocampal activity with neurogenesis, learning and memoryNature Genetics, 2004